Central Nervous System Epilepsy

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Epilepsy Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Epilepsy Projects
--Barr Pharmaceuticals Inc
--Banner Pharmacaps
--Biovail Corporation
--Bial Group
--D-Pharm Ltd
--Caraco Pharmaceutical Laboratories Ltd
--Johnson & Johnson
--Eisai Co Ltd
--NeuroSearch A/S
--Mylan, Inc.
--OVATION Pharmaceuticals, Inc.
--Noven Pharmaceuticals Inc
--SK Bio-Pharmaceuticals
--Sepracor Inc
--Teva Pharmaceutical Industries Ltd
--Taro Pharmaceutical Industries Ltd
--Valeant Pharmaceuticals International
--UCB S.A.
--Zydus Cadila Healthcare Limited
--WOCKHARDT LIMITED

--Top Companies in early stage Epilepsy Projects
--Cambria Biosciences
--Anavex Life Sciences Corp.
--CyDex Pharmaceuticals, Inc.
--Celentyx Limited
--ICAgen Inc
--GW Pharmaceuticals PLC
--Neurologix Inc
--Neuro-Hitech Pharmaceuticals Inc
--Novartis AG
--Neurorecovery, Inc.
--Penwest Pharmaceuticals Co
--Noven Pharmaceuticals Inc
--Valeant Pharmaceuticals International
--Spherics, Inc

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View